With Lionsgate stock hitting another record high, CEO Jon Feltheimer sounded a bullish outlook for prospects for its "Hunger Games” franchise at the company's annual shareholders meeting in Toronto…
With “The Hunger Games” and “Twilight” fueling Lionsgate's profits and stock price, the studio has rewarded its top execs with sharply increased pay. Lionsgate paid $28.2 million to vice chairman…
Less than two years ago, Lionsgate reached a settlement with Carl Icahn that called for the billionaire investor to cash out his 33% stake for $309 million, essentially breaking even on a three-year…
Domestic Film WEEKEND OF
PROVIDED BY: Box Office
The Maze Runner
The Maze Runner1Weekend:$32.5M
A Walk Among the Tombstones
A Walk Among the Tombstones2Weekend:$13.1M
This Is Where I Leave You
This Is Where I Leave You3Weekend:$11.9M
Summit Entertainment and Lionsgate have agreed to walk down the aisle, combining the town's leading minimajors in a complex cash and stock deal worth $412.5 million.
After years of wrangling, Lionsgate and Carl Icahn have reached a peace accord, with the billionaire investor selling his 33% stake in the company.
The war between Lionsgate and Carl Icahn has escalated as part of a proxy fight for control of the minimajor.
Lionsgate's dialing up a campaign to persuade MGM's debtholders to choose its merger proposal rather than a rival reorganization plan that would leave Spyglass Entertainment toppers in charge.
Carl Ichan's blistered the management of Lionsgate and officially notified the minimajor that he'll launch a proxy fight to take over the board of directors.
Lionsgate will include Carl Ichan as a voter in its upcoming shareholder vote on a poison pill that's designed to make it more difficult for Icahn to complete a hostile takeover of the minimajor.
Lionsgate is urging its shareholders to enact a poison pill provision that would make it far more difficult for Carl Icahn's hostile takeover to succeed.